Endocrine Therapy for Hormone Receptor Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Summary-Reference-Cited by-同舟云学术

Endocrine Therapy for Hormone Receptor Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Summary

Published:2016-06 Issue:6 Volume:12 Page:583-587
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Rugo Hope S.¹,Rumble R. Bryan¹,Burstein Harold J.¹

Affiliation:

1. University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; American Society of Clinical Oncology, Alexandria, VA; and Dana-Farber Cancer Institute, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2016.012914

Reference7 articles.

1. Cancer statistics, 2015

2. Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover

3. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

4. Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

5. Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Combination Therapy in Breast Cancer Treatment;Highlights in Science, Engineering and Technology;2022-08-17

2. Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting;BMC Proceedings;2021-08

3. Understanding Molecular Process and Chemotherapeutics for the Management of Breast Cancer;Current Chemical Biology;2021-04-27

4. De-escalation towards omission is the tipping point of individualizing breast cancer surgery;European Journal of Surgical Oncology;2020-08

5. Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer;JAMA Network Open;2020-07-09